Literature DB >> 6302210

Rotavirus persistence in cell cultures: selection of resistant cells in the presence of foetal calf serum.

A Chiarini, S Arista, A Giammanco, A Sinatra.   

Abstract

The Lincoln strain of bovine rotavirus, cytocidal for bovine AU-BEK cells, can establish in the same cell cultures in the presence of foetal calf serum (FCS) a persistent infection that depends on selection of highly resistant cells. In fact, after the induction of the carrier state only a small fraction of the cell population was infected. The parental and the carried viruses are not demonstrably different, the cultures are resistant to superinfection by the homologous virus, the cultures can be cured by antiviral serum in the medium and uninfected resistant cell clones can be selected. The presence of FCS was essential during induction and maintenance of persistence. Its effects appear to be exerted not on the control of virus replication in fully sensitive cells but on the proliferation and selection of the resistant cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302210     DOI: 10.1099/0022-1317-64-5-1101

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

Review 1.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

2.  Cultivation of avian rotaviruses in chicken lymphocytes and lymphoblastoid cell lines.

Authors:  K A Schat; T J Myers
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism.

Authors:  C Escarmís; E C Carrillo; M Ferrer; J F Arriaza; N Lopez; C Tami; N Verdaguer; E Domingo; M T Franze-Fernández
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells.

Authors:  J Z Mrukowicz; J D Wetzel; M I Goral; A B Fogo; P F Wright; T S Dermody
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.